resTORbio, Inc.
(NASDAQ : TORC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.68%200.011.3%$739.64m
GILDGilead Sciences, Inc.
-1.81%63.060.9%$367.98m
CELGCelgene Corporation
-0.96%94.791.3%$322.84m
ALXNAlexion Pharmaceuticals, Inc.
-6.13%115.932.0%$288.15m
ILMNIllumina, Inc.
-2.95%280.073.5%$268.94m
BIIBBiogen Inc.
-1.75%228.001.3%$263.36m
VRTXVertex Pharmaceuticals Incorporated
-1.35%181.761.9%$253.17m
EXASExact Sciences Corporation
-1.17%116.4924.1%$237.08m
REGNRegeneron Pharmaceuticals, Inc.
-1.65%290.142.6%$200.04m
AAgilent Technologies, Inc.
-2.91%69.651.6%$188.24m
SRPTSarepta Therapeutics, Inc.
-0.49%94.6014.7%$183.68m
BMRNBioMarin Pharmaceutical Inc.
-1.58%76.184.3%$95.93m
INCYIncyte Corporation
-3.34%82.702.5%$92.85m
GHDXGenomic Health, Inc.
-0.41%73.221.8%$85.64m
SGENSeattle Genetics, Inc.
-2.20%76.646.5%$77.82m

Company Profile

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.